Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540353 · ClinicalTrials.gov registry record · NA
Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.
A NA study, sponsored by Medstar Health Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05540353 is a NA study that was terminated before completion, run by Medstar Health Research Institute. The registered enrollment target is 6 participants.
The verdict
NCT05540353, a NA study, was terminated before completion, sponsored by Medstar Health Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Dyspareunia is defined as pain with penetrative sexual intercourse. Women with endometriosis have a nine-fold increased risk of dyspareunia, when compared to the general female population. A prospective single-blinded randomized controlled trial will be performed evaluating the change in pelvic pain and sexual satisfaction scores from baseline to 6 weeks after treatment with transvaginal photobiomodulation therapy or sham therapy. Treatment will involve 9 planned treatment sessions over 3-4 weeks. 40 women will be included in the study.
Interventions
- DEVICE Transvaginal photobiomodulation
- DEVICE Sham therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05540353
The ClinicalTrials.gov registry entry for NCT05540353 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transvaginal photobiomodulation is the first listed.
NCT05540353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05540353 about?
NCT05540353 is a clinical study titled "Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.". Dyspareunia is defined as pain with penetrative sexual intercourse. Women with endometriosis have a nine-fold increased risk of dyspareunia, when compared to the general female population. A prospective single-blinded randomized controlled trial will be performed evaluating the change in pelvic pai...
What is the current status of trial NCT05540353?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2023-05-02. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT05540353?
The interventions under investigation include: Transvaginal photobiomodulation (DEVICE), Sham therapy (DEVICE).
Who is sponsoring clinical trial NCT05540353?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.